Skip to main navigation
Skip to search
Skip to main content
Maastricht University Home
Support & FAQ
Link opens in a new tab
Search content at Maastricht University
Home
Researchers
Publications
Activities
Press/Media
Prizes
Organisations
Dataset/Software
Projects
Recent Advances in Antiarrhythmic Drug Therapy
Arnela Saljic
,
Jordi Heijman
, Dobromir Dobrev
*
*
Corresponding author for this work
Cardiologie
Carim - Clinical atrial fibrillation
Carim - Arrhythmogenesis and cardiogenetics
Research output
:
Contribution to journal
›
Article
›
Academic
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Recent Advances in Antiarrhythmic Drug Therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Ventricular Arrhythmia
100%
Recent Advances
100%
Antiarrhythmic Therapy
100%
Antiarrhythmic Drugs
40%
Antiarrhythmic Agents
40%
Atrial Fibrillation
20%
Pharmacological Treatment
20%
Cause of Death
20%
Repurposing
20%
Molecular Mechanism
20%
Drug Development
20%
Rhythm Control
20%
Cause of Disability
20%
Antiarrhythmic Effect
20%
Clinical Development
20%
Arrhythmia Management
20%
Common Cause
20%
Treatment Opportunity
20%
Drug Repurposing
20%
Existing Drugs
20%
Regulatory Approval
20%
Financial Considerations
20%
Drug Agents
20%
Development pipeline
20%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Arrhythmia
100%
Pharmacotherapy
100%
Antiarrhythmic Agent
100%
Drug Development
20%
Atrial Fibrillation
20%
Repurposing
20%
Drug Repositioning
20%
Antiarrhythmic Drug
20%
INIS
therapy
100%
drugs
100%
patients
20%
increasing
20%
control
20%
reviews
20%
death
20%
management
20%
pipelines
20%